Advertisement

The Latest

Carlsmed saw significant gains in fourth-quarter and 2025 revenue, according to financial results posted Feb. 25. Five things to know: 1. Full-year revenue was $50.5 million, an 86% increase from 2024. Fourth quarter revenue grew 61% with $15.2 million. 2.…

The Activ-L lumbar artificial disc is back on the U.S. market under Highridge Medical, and its first cases under the company were completed in February, Scott Blumenthal, MD, told Becker’s. Highridge announced plans in 2025 to introduce Activ-L after Aesculap,…

Gregory Gebauer, MD, of the Surgery Center of Greensboro (N.C.) is the first surgeon in Greensboro to offer Barricaid, Intrinsic Therapeutics said in a Feb. 25 LinkedIn post. He previously used the system for discectomy patients at his practice in…

The FDA granted 510(k) clearance to 4Web Medical’s SI joint truss system, according to a Feb. 25 news release. The system is indicated for sacroiliac joint fusion to address sacroiliac joint dysfunction including sacroiliac joint disruption and degenerative sacroiliitis. It…

With more and more spine technologies entering the market, the decision whether to invest can be met with challenges between physicians and other stakeholders. It’s a problem that Philip Louie, MD, said he wants to change. “Every time we bring…

Phoenix-based Southwest Orthopedic and Spine Hospital agreed to pay $5.6 million to resolve alleged Stark law violations, according to a Feb. 24 Justice Department news release. The hospital, operating as Oasis Hospital, USPI and Dignity/USP Phoenix Surgery Centers agreed to…

Three organizations named new orthopedic leaders in February, all choosing physicians to oversee clinical operations, specialty services and broader institutional leadership. 3. Little Rock-based The University of Arkansas for Medical Sciences appointed orthopedic surgeon and joint replacement specialist Lowry Barnes,…

Sports medicine physician David Kruse, MD, will serve as head team physician for Team USA’s Milan Village Sports Medicine Clinic at the 2026 Paralympic Winter Games, Cedars-Sinai said in a Feb. 25 news release. The games will take place from…

Medtech company Catalyst OrthoSciences has received FDA 510(k) clearance for its Archer Patient-Specific Instrumentation.  The shoulder arthroplasty technology is a suite of humeral and glenoid guides that helps orthopedic surgeons improve precision, consistency and confidence, according to a Feb. 25…

Advertisement